- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Trophy buy adds to Trex results
Radiography firm Trex Medical of Danbury, CT, reported that net income for the third quarter (end-July) climbed 54% to $5.6 million from $3.7 million for the same quarter the previous year. The company's revenues were $72.1 million, as compared with
Radiography firm Trex Medical of Danbury, CT, reported that net income for the third quarter (end-July) climbed 54% to $5.6 million from $3.7 million for the same quarter the previous year. The company's revenues were $72.1 million, as compared with $58.1 million in the third quarter of 1997.
Trex's increased sales were a result of its acquisition of Trophy Radiologie in April, as well as growth in its fluoroscopy, mammography, and cardiac catheter laboratory products, according to Hal Kirshner, president and CEO.
In other Trex news, the company announced July 23 that its Trophy division won a $10 million contract with the Department of Health for the Republic of the Philippines. The contract is guaranteed through a loan to the Philippines from the French government, and Trophy will supply medical x-ray equipment such as stationary and mobile general-purpose systems and radiographic/fluoroscopic systems. Trex expects shipments to begin in early 1999.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
